Evidence and Value-Based Purchasing for Value Analysis. Part 3 of 4.

Evidence and Value-Based Purchasing for Value Analysis. Part 2 of 4.

We Keep Talking About Evidence…So What Is It?

Hayes Reports Payers Are Viewing in 2017

Evidence and Value-Based Purchasing for Value Analysis. Part 1 of 4.

Critical Evidence Appraisal: There’s a Method(ology) to Our Madness

Speakers Confirmed for Hayes 2017 Client Symposium

NPR Segment Features Treatments for Low Back Pain

Getting to Know Hayes: Beth Bontemps, Product Manager, Prognosis and News Service

Top 3 Hayes Reports: 1st Quarter, 2017

What Is the Role of Value Analysis in Bundled Payment Success?

“Dumb Data”: If I Only Had a Brain

On the Horizon: CAR T-Cell Therapy for Cancer Treatment

Getting to Know Hayes: Mary McCabe Paine, RN, MPhil, DHSc, Director of Clinical Services

Tips for Supply Chain to Improve Physician Buy-In. Part 4 of 4.

Approaches to Genetic Testing: Somatic vs Germline

Does Evidence Have a Role in Treating the Opioid Epidemic?

New Methodology Webinar Focuses on Supply Chain and Value Analysis

Big Data, MACRA, and Evidence: What’s the link?

There Are No Alternative Facts About Evidence-Based Medicine

Innovation at Hayes Begins with Our Clients

Tips for Supply Chain to Improve Physician Buy-In: Part 3 of 4

Evidence: We Set the Gold Standard

3 Questions with Dr. Nierman of Tufts Health Plan

Tips for Supply Chain to Improve Physician Buy-In: Part 2 of 4

The 2017 Second Annual Hayes Client Symposium

We’ve Got Your Back: Earn CE Credits with Our Vertebral Compression Fracture Webinar

Get Engaged: Tips for Supply Chain to Improve Physician Buy-In: Part 1 of 4

Analytical Validity, Clinical Validity, and Clinical Utility: What’s the Difference?

Phil Is Flawed: Groundhog Day’s Startling Lack of Evidence

Evidence-Based Medicine and the Necessity of Science

JAMA: Sepsis Responsible for Highest Rate of Hospital Readmissions

NPR Piece: “Research-Quality” Data Crucial to EHR-Guided Treatment

Evidence Key to CMS dollars for Hospital Acquired Conditions

FDA Approves New Treatment for Spinal Muscular Atrophy

Neptune Waste Management System Back in Operating Suites

The Hayes Year in Review

510(k) vs PMA: Do you know the difference?

MediHoney vs TheraHoney: What’s All the Wound-Healing Buzz About?

5 Health Technologies to Watch in 2017

When a Health Technology Assessment Cost Us $100,000

Peanut Allergy Drug Therapies Make National Headlines

3 Ways Evidence Assists Coverage Policy Determination

Getting to Know Hayes – Shannon Brode, MPH; Product Manager, Health Technology Briefs, Evidence Solutions

CMS Weighs the Evidence for Leadless Pacemaker Coverage

The Rules of Physician Engagement

Evidence Shines a Light on the Hidden Dangers of Genetic Testing

Can Health Technology Assessments Save Payers and Consumers Billions?

From Analog to Digital and Beyond: The 25-Year Evolution of the Hayes Medical Technology Directory

You Can’t Afford to Say “So What” to Evidence-Based Practice

20 Questions? How about 10? Making Technology Acquisition Decisions at the 2016 AHVAP Conference

The 2016 Inaugural Hayes Client Symposium: Calling All Ships to Shore

Cacophony or Symphony? How to Orchestrate Population Health Management

Leading the Way: Giving Genetic Testing Context

Getting Health Plans & Providers in Sync with Genetic Tests

When Vendors Say They Are “Evidence-Based,” What Does That Really Mean?

It’s FDA Approved! But is it Ready for My Coverage Policy?

The Quandary of Making Healthcare Technology Acquisitions without Evidence

When Tamiflu Doesn’t Tame the Flu

Specialty Pharma: A Prescription for Controlling Catastrophic Costs

Ameda or Medela: Which breast pump is better?

Aligning Doctors to Improve Quality at Memorial Hermann

Why Not Now?

Why Smart Healthcare Executives Are Focusing on Evidence-Based Medicine

Our Inaugural Hayes Client Symposium

Hayes Report on Total Artificial Heart Now Available

Rapid Strep Test not Limited to Labs Anymore

How Do We Talk to Patients About End-of-Life Care?

The Evidence Behind Prophylactic Salpingectomy for the Prevention of Ovarian Cancer

Hayes, Inc. at AHIP: Health Plan Transformation

Another Example of Evidence Changing Over Time

New Cancer Diagnostic Test Enters the Market

Hayes at AHIP: Using Data Analytics Gives Health Plans a Leg Up

Why Don’t Physicians Adhere to Best Practices?

Aetna Curbs Coverage for Procedures Using Power Morcellators

The Impact of Disaster Planning on Hospital Emergency Preparedness

Is Promotion of Off-Label Drug Use a First Amendment Right?

Farewell, Dr. David L. Sackett

More Evidence Debunks Link Between MMR Immunization and Autism

What Our Clients Want to Know: BART Testing: What are marketplace standards in coverage?

Update on Accountable Care Organizations

Collaboration Improves Patient Safety

Congress Votes for Permanent Physician Payment Fix

Patient Engagement Is a Priority for Hospital IT Leaders

Do You Need to Boost Your Genetic and Genomic Literacy?

Is the Next Drug-Pricing War on the Horizon?

Making Tough Choices

NICE Guidance Recommends Sovaldi and Olysio

What Our Clients Want to Know: Sepsis Care Bundles

What Our Clients Want to Know: Biotene or CHG: Which is Better for Prevention of Ventilator-Associated Pneumonia?

FDA Issues Guidance on Mobile Medical Applications

Avycaz Approved to Treat Superbug Infections

Are We Using the Right Formula to Evaluate Hospitals’ Performance?

Institute of Medicine Proposes New Diagnostic Criteria for Chronic Fatigue Syndrome

To Immunize or Not to Immunize: The Debate Continues

Hayes Viekira Pak Report Is Now Available

Will We Be Able to Afford PCSK9 Inhibitors?

Changing the Way We Pay for—and Deliver—Care in the United States

Are We Asking the Right Questions About Genetic Tests?

FDA Issues Guidance on General Wellness Devices

Is most cancer the result of “bad luck”?

FDA Approves In.Pact Admiral Drug Coated Balloon for Treatment of PAD

What Our Clients Want to Know: What’s New in Spine Hardware and Implants?

FDA Approves Gardasil 9 HPV Vaccine

Quality of Noninvasive Prenatal Tests Questioned

FDA Panel Recommends Approval for New IV Antibiotic Product

Preimplantation Genetic Diagnosis: Are We Stopping the Spread of Dangerous Genes or Opening Pandora’s Box?

More Information to Consider About Genetics and Breast Cancer

FDA Advisory Committee Votes to Retain Black Box Warning for Chantix

CDC Now Advises No Skin Exposure for Hospital Workers Caring for Patients with Ebola

Primary Prevention of MI: Swedish Study Demonstrates Significant Impact of Lifestyle Choices

CDC Updates Management and Preparation Resources for Ebola in the U.S.

FDA Cracks Down on Social Media

USPSTF Recommends Behavioral Counseling for Overweight Adults with Cardiovascular Risk Factors

FDA Issues Action Plan for More Inclusive Clinical Trials

Selling Science or Snake Oil?

Growth of Evidence-Based Medicine in Asia

Study Design and Execution Matter!

Can a Test to Detect a Gene Variant Predict Suicide Risk?

Are We Getting Closer to Personalized Medicine?

FDA Approves First Single-Dose IV Antibiotic to Treat Acute Bacterial Skin Infections

The Debate over FDA Regulation of LDTs Heats Up

RCT Finds Sutures Better than Staples for Closing C-Section Incision

The Changing Landscape of Hepatitis C Treatment

FDA Advisory Panel Set to Review Ablatherm HIFU System for Prostate Cancer

ACP Finds No Benefit in Routine Screening Pelvic Exam

FDA Approves Novel Inhaled Insulin

Efforts to Cut Unnecessary Blood Testing Bring Major Decreases in Healthcare Spending

Is Better Genetic Diagnosis of Autism Possible?

Cochrane Library: Herceptin Benefits Outweigh the Risk of Harm

New Strategies to Combat MRSA in Hospitals

Opening the Pandora’s Box of Genetic Information

Newly Approved Treatment for Hemophilia A

Evidence Leads to Medicare Policy Change

Real-Life Implications for Misinterpretation of Direct-to-Consumer Genetic Testing Results

Public Workshops on FDASIA Health IT Report: What Happens Next?

FDASIA Health IT Report: Where Do We Go From Here?

Is a Blood Test for Depression Really on the Horizon?

Are High Endogenous Testosterone Levels Performance-Enhancing in Women?

FDA Addresses Potential Cancer Risk Associated with Laparoscopic Device

New Strategy to Rule Out MI in the Emergency Department

Wrap-up from the 2014 Annual Meeting of the American College of Medical Genetics and Genomics

Highlights from the 2014 Annual Meeting of the American College of Medical Genetics and Genomics

Highlights from the 2014 Annual Meeting of the American College of Medical Genetics and Genomics

Who Is Funding the Research and Does That Matter?

Don’t Miss Our Poster Presentation at the ACMG Annual Clinical Genetics Meeting

DECODING THE HYPE: Blood Test to Predict Alzheimer’s Disease?

Changes in the SATs Include “Evidence-Based” Thinking

Is Gene Editing the Future of Gene Therapy?

Variation in Clinical Trial Evidence: A Balancing Act

DECODING THE HYPE: Mind Your ABCs…

On the Horizon: New Method to Stop Hemorrhages On and Off the Battlefield

New Research Adds More Fuel to the Mammography Debate

Clinical Practice Guidelines: A Cautionary Tale

More from Medicaid Innovations 2014

IOM Discusses Challenges Associated with Using Genomic Sequencing for Clinical Purposes

What’s the Buzz at Medicaid Innovations 2014?

Science and the Super Bowl

We’ll Be on the Road at the World Congress Health Care Supply Chain Summit

DECODING THE HYPE: Vitamin D and Multiple Sclerosis

FDA Approves Sofosbuvir for Chronic Hepatitis C

DECODING THE HYPE: Desensitizing Kids to Peanut Allergies

Overdiagnosis of Lung Cancer in the National Lung Cancer Trial

American Academy of Pediatrics Issues Updated Guidance on Treating URIs

Some of Our Most Popular Posts in 2013

DECODING THE HYPE: Vitamin D—a Bone of Contention?

Patients-in-Waiting—an Unintended Consequence of Genetic Screening

CMS Issues Proposed Decision Memo to Cover Cardiac Rehabilitation Services for Chronic Heart Failure

Choosing Wisely Initiative Releases Latest List of Inappropriate or Overused Tests and Procedures

DECODING THE HYPE: Should All Men Be Taking Testosterone?

FDA orders 23andMe to cease and desist—is this the beginning of the end for direct-to-consumer genetic testing?

Scientific Abstracts Are not as Accurate as You Think

Reimbursement for Molecular Tests – The Controversy Continues

On Thanksgiving, Celebrate by Learning Your Family Health History

DECODING THE HYPE: Controversy Continues Regarding New Heart Disease Guidelines

Overuse of Cardiac Stents Is Old News to Us

Achieving Sustainable Improvements in Clinical Outcomes and Cost Savings Is Easier than You Think

Post Two Tweets and Call Me in the Morning

Mining the Mysteries of Big Data

HeLa Cells, Patient Privacy, and Biomedical Research

When Evidence Goes Bad

Truth, Lies, and the Internet

Treatment for Outpatient Back Pain Misaligned with the Evidence

Getting to the Heart of the Echocardiogram Problem

Dee Donatelli Speaking at AHRMM13 Conference

New Guidance on Fecal Bacteriotherapy

What’s responsible for the slowdown in healthcare spending?

Joint Commission and PCPI Recommend Strategies to Minimize Overuse of Five Common Treatments

Will the FDA Move to Regulate Laboratory-Developed Tests?

Screening Guidelines Don’t Necessarily Translate to Practice

Rethinking the Evidence for Controlling ICU-Based MRSA Infections

Bridging the Evidence Gap to Treat Obesity

Supreme Court Rules that Genes Are not Patentable!

Biased Science Gets More Press in Selling Sickness 2013

How Does Your Institution Decide Which Health Technologies to Adopt?

Congress Must Act to Retain the Autonomy of the U.S. Preventive Services Task Force

Hospitals Can Deliver High-Quality Care and Save Money

FDA Takes Firm Stance on Fecal Transplant for “Lack of Evidence”

Saving Lives Through Genetic Testing and Prophylactic Surgery

Chief Medical Officers: Today’s Leaders in Reducing Costs and Improving Clinical Value

Why Is Medicare Slow to Set Reimbursement Rates for Molecular Tests?

Join Us at the 2013 Spring IDN Summit and Reverse Expo

Is a compromise the answer in the gene patenting debate?

Genetic Testing Must Have More Oversight

Hype, Hope, and Evidence

Roger That!

Choosing Wisely Initiative Gains Momentum

Will the U.S. Supreme Court Confirm That Our Genes Can Be Patented?

Robots, Costs, and Clinical Outcomes

Our Latest Hybrid Operating Room Trend Report Is Available

High-Tech Versus Low-Tech: Using Evidence to Guide Treatment Options

The Heavy Lifting of Healthcare Reform

New Evidence Raises Concerns About Safety of Pradaxa in Patients with Mechanical Heart Valves

Black Box Warning for Incivek

Using Evidence to Kick the “Ick” Factor

FDA Approves New Anticoagulant to Reduce Stroke Risk

Genetic Testing Algorithms Debut This Month

Looking for Hospital Admission Statistics? AHRQ Has Them

Musings from the Managing Editor, Hayes News Service

Exploring the Science of KRAS Gene Testing

How Well Are Your Value-Analysis Efforts Working?

We Now Offer Customized Support for Coverage Policy Development for Molecular Tests

Why Does Congress Want to Defund Objective Research?

Focus on Value Analysis

With Whom Do You Associate?

Hot Topics at the 36th Annual Scientific Meeting of the Canadian College of Medical Geneticists (CCMG)

New and Emerging Technologies in the Diagnosis of Genetic Diseases

Getting Closer to Understanding the Genetics of Autism Spectrum Disorder

Kudos to GlaxoSmithKline

Does 3D Mammography Save Lives?

Personalized Medicine for Patients with Cancer: Not Quite Ready for Prime Time

Read Our Latest White Paper to Learn How One Health System Reduced Annual Costs of Surgical Mesh By 50%

The HFMA Value Project

At the Hayes News Service, We Never Rely on Abstracts Alone!

How Safe Are Hospital Patients?

Live from the IDN Summit

What’s Your Plan For Reducing Hospital Readmission Rates?

Transitioning to Value-Based Care

Does Whole Body Vibration Stimulate Bone Growth in Postmenopausal Women?

An Interview with Dee Donatelli

Unnecessary Medical Imaging Increases Breast Cancer Risk

Is Robotic Hysterectomy Really Better Than Laparoscopic Hysterectomy?

Expert Advice on Genetic Testing Approaches Yields Significant ROI

Hayes Welcomes Dee Donatelli

2012 HTAi Annual Meeting Ends with Focus on Information/Communication Technology

CER Is Alive and Well with SCOTUS Decision on the Affordable Care Act

Affordable Care Act Hangs in the Balance

Additional Insights from the 2012 HTAi Annual Meeting

An Update from the 2012 HTAi Annual Meeting

What’s Your Plan For Reducing Hospital Readmission Rates?

Can Cognitive-Behavioral Therapy Eliminate the Binge-Purge Cycle of Bulimia?

To Test or Not To Test

Stop By and Say Hello

Is the Telemedicine Trend Good for Patients, Payers, and Providers?

Do Injections of Bone Cement Safely Relieve the Pain of Vertebral Fractures?

We’re Helping Providers Improve Their Utilization Management Processes

Don’t Miss Our Contribution to Medical Tourism Magazine!

Whose Evidence is Most Important to You?

Knee Shopping

Reading Beyond the Headlines

Healthcare Industry Takes a Step Toward Eliminating Wasteful Spending

Check Out Our Newest White Paper

Does Your Organization Use an Evidence-Based Value Analysis Process?

Antibacterial Sutures: Do They Really Reduce the Number of Surgical-Site Infections?

Is the Federal Blueprint for Health Insurance Exchanges Too Ambitious?

Spinal Cord Stimulation: Potential But Unproven Treatment for Patients with Neuropathic Pain

How Ready Are You for Change?

Live From Las Vegas

Do You Need a New Approach to Contrast Media Selection?

Senior Executives, Will You Be Ahead of the Curve?

Take Heart: Minimally Invasive Coronary Artery Bypass Graft Surgery Enters the Operating Room

New Molecular Testing CPT Codes Offer Clarity for Payers and Providers

Improving Outcomes and Lowering Costs with Disease Registries

Repeat After Me: Expensive Doesn’t Mean Better

Botulinum Toxin (Botox) as Treatment for Migraine Headaches

Some Take-Away Messages from the Military Health System Annual Conference

The Five Rights of Hospitals and Providers

We’re Heading to the 2012 Military Health System Conference

11 Mistakes Hospitals Make When Adopting New Technologies

Journal of Healthcare Contracting: Improving value analysis processes

Beware of Bias: Consumer Health Misinformation on the Web

Check Out Our New Reports

IMDA Interview: Expect Continued Demand for Evidence in 2012

Evidence Makes Its Mark in 2011

Don’t Rely on Abstracts When Answering Questions About Efficacy and Safety

Complimentary White Paper Identifies 10 Questions That Hospitals Should Ask When Making Technology Acquisition Decisions

The Demonization of Comparative Effectiveness Research

Do We Really Need to Screen All Children for High Cholesterol?

Deficit Reduction Law Makes Comparative Effectiveness Research More Important Than Ever

The Results Are In: The Most-Requested Genetic Testing Topics

Today is Veterans Day

Download our Latest White Paper Advocating an Evidence-Based Approach to Medicare Coverage Policy Determinations

Rethinking Treatments for Low Back Pain

When “More” Is not “Better”

What Doesn’t Work for Women with Breast Cancer?

Should Health Literacy Be the Newest Vital Sign?

71st Annual Conference of the American Medical Writers Association

October is Health Literacy Month

Evidence-Based Evaluation Versus Consensus Guidelines: Why They Don’t Always Jibe

Personalized Medicine: What Does the Evidence Tell Us?

Are We Harming Patients by Rushing Genetic Tests to Market?

Join Me For a Webinar on Comparative Effectiveness Research

It’s official. We’re recertified!

IOM Report on 510(k) Process Criticized Before Publication

The Role of Evidence in ACOs

What Happens When Expensive Healthcare Technologies Fail to Improve Patient Care and Clinical Outcomes?

It’s Alphabet Soup Out There!

Healthcare Technology: Are We Getting Our Money’s Worth?

Are You Ready for New CPT Codes for Molecular Tests?

What Can We Do When the Demand for a Controversial Technology Surpasses the Evidence?

Does Data Distortion Harm?

Join Me at CMSA in San Antonio, TX

What’s Spin Got to Do With It?

Are Hospitals Misleading Patients About the Benefits of Robotic Surgery?

Is Industry-Funded Research Biased?

Speaking From Experience…

Direct-to-Consumer (DTC) Genetic Testing – Boon or Bane?

Implementing New Guidelines for Alzheimer’s Disease: Evidence Will Play a Key Role

What Is “Good” Evidence?